Loading...

BEAM BEAM THERAPEUTICS INC Company Mergers 8-K Filing

BM T

BM

BEAM THERAPEUTICS INC

(BEAM)

2026 8-K

License Termination

$500 Million Financing

License Agreement Update

Director Resignation

Financial Estimate Update

Asset Acquisition Update

Financial Results Announced

Asset Acquisitions

Positive Trial Data

Financial Results

Financial Update

Clinical Trial Updates

Management Change

Board Expansion

Clinical Trial Updates

Financial Results

Earnings Reports

Resignation and Appointment

Annual Meeting Voting Results

Earnings Reports

Earnings Reports

Financial Update

Board Expansion and New Dir...

Financial Results Announcement

Completion of Acquisition o...

Costs Associated with Exit ...

Financial Results Announcement

Annual Meeting Voting Results

Agreement with Jefferies LLC

Earnings Reports

Financial Results Announcement

Financial Results

External Links:

Beam Therapeutics Inc. terminated its License Agreement with Bio Palette Co., Ltd. on March 2, 2026, due to Bio Palette's planned dissolution; this action activated a standby license from Kobe University, ensuring continuity for Beam's patent rights.

AI Assistant

BEAM THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.